Top

Tag: ADT


FDA, Regulations

Bayer’s Nubeqa receives FDA approval to treat metastatic prostate cancer

August 9, 2022

Via: PMLiVE

The decision was based on the ARASENS trial, which demonstrated that adding Nubeqa to standard androgen deprivation therapy (ADT) and docetaxel chemotherapy led to a statistically significant improvement in overall survival compared to ADT plus docetaxel and placebo. The results, […]